Is laziness a personal choice or a genetic trait?

Last Updated on

November 02, 2019 – Is laziness a choice or genetic trait? At the age where genetics seems to explain everything, it is certainly interessant to learn that a seemingly personal choice such as laziness as such may loom somewhere in your genetic outfit. Perhaps, you can not escape your laziness behaviour, because it is part or your make-up, based on your very own genetic backing? If nothing else, this is at least a fascinating thought and would help to explain a lot of things, among them recurring lifestyle issues.


Regular physical activity is a crucial part of living a healthy lifestyle. However, a majority of adults spend their waking hours sitting, which leads to a variety of health issues such as obesity, cardiovascular disease and cancer. Recent research at the University of Missouri has identified a specific gene related to physical inactivity in rats that could potentially play a role in sedentary behavior in humans as well. Previously, research has shown that genes may play some role in physical inactivity of individuals. Since in humans, inactivity may lead to chronic disease, there has been for long time a quest for identifying genes involved in this phenomenon. Newest research has now discovered one such gene, namely the Protein Kinase Inhibitor Alpha gene (PKIA gene), that seems to play a significant role in the phenomenon of human laziness.

Thus, in a long term study since 2009, researchers took 80 male rats and bred them with 80 female rats. They then placed the rats in voluntary running wheels, similar to those sold in pet stores, and tracked which rats ran the most and least. Over the past decade, the researchers then selectively bred the highly active rats with each other as well as the “lazy” rats with each other to determine if there is a difference in their genetic makeup. The researchers found that the PKIA gene was significantly less present in the “lazy” rats. While this study was done in rats, it may nevertheless be rather relevant to humans to in that the PKIA gene in humans codes for exact the same molecular and physiological function as its homologue counterpart in rats.

Generally, common believe holds that physical inactivity in humans may contribute to more than 40 chronic diseases. Rather than focusing on ways to treat chronic diseases after they have already developed, understanding the contributing factors to physical inactivity, particularly genetic predispositions to it,  could help prevent those chronic diseases from occurring in the first place, in that individuals at risk for non-activity (i.e., seeming laziness) could be more specifically motivated to increase prophylactic physical activities without falsely accusing the patients for their (inborn) tendency for being lazy.

According to US government data, costs associated with physical inactivity total $138 billion and account for more than 11 percent of total health care expenditures. In addition to the financial benefits of a more physically active society a better understanding of genetic makeup could help public health officials see physical inactivity as a crucial priority to address. One difficulty of most chronic diseases is that they usually are not caused  by just one gene. For example, there are more than 150 gene variations involved in type 2 diabetes. The present study helps to identify other genes that might be involved in physical inactivity in humans as well and to identify additional factors that may help to prevent 0r at least reduce chronic disease development.

The study “Overexpression of Protein Kinase Inhibitor Alpha Reverses Rat Low Voluntary Running Behavior” was published in the Journal “Molecular Neurobiology”.

See here a short sequence on “laziness”:


Print Friendly, PDF & Email





Tags: , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


@peepso_user_7542(Menlo-50) With me, it must be genetic.... I am fighting my laziness, but without success.

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Metabolomics meets genomics to improve patient diagnosis July 7, 2020
    A patient and family walk into a doctor's office. They hope that the latest tests will reveal what is causing the patient's illness and end the diagnostic odyssey they have been going through for years. Having an accurate diagnosis also means that maybe there is a treatment that at least can alleviate the patient's condition.
  • Researchers develop new approach to study the genetics of human disease July 7, 2020
    Many heritable immune diseases such as rheumatoid arthritis and blood-cell related traits derive from critical proteins not being made or not functioning correctly. But exactly how a person's genes, the regulation of these genes and how the resulting proteins interact to cause disease is not widely understood.
  • Common inherited genetic variant identified as frequent cause of deafness in adults July 6, 2020
    A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research published online in the Journal of Medical Genetics.
  • Rsearchers create an analytic tool that opens a new frontier of cancer discovery July 6, 2020
    Gene coding regions constitute 2% of the human genome. St. Jude Children's Research Hospital scientists have developed a computational tool to identify alterations that drive tumor formation in the remaining 98% of the genome. The method will aid discovery of oncogenes and advances in precision medicine for children and adults with cancer.
  • Discovery of new disease-susceptibility gene for steroid-sensitive nephrotic syndrome July 3, 2020
    An international research collaboration, including Professor Iijima Kazumoto et al. (of the Department of Pediatrics, Kobe University Graduate School of Medicine) has revealed that NPHS1 is a disease-susceptibility gene for steroid-sensitive nephrotic syndrome in children. The NPHS1 gene encodes nephrin, a component protein for the renal glomerulus slit diaphragm, which prevents protein from being passed […]
  • Hearing and visual impairments linked to elevated dementia risk July 8, 2020
    Older adults with both hearing and visual impairments--or dual sensory impairment--had a significantly higher risk for dementia in a recent study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
  • Certain jobs linked to higher risk of knee osteoarthritis July 8, 2020
    Workers in jobs that typically involve heavy lifting, frequent climbing, prolonged kneeling, squatting, and standing face an increased risk of developing knee osteoarthritis. That's the conclusion of a new analysis published in Arthritis Care & Research.
  • Bacteria in infants' first stool may indicate their risk of obesity July 8, 2020
    Meconium--the earliest stool of an infant -- is composed of materials ingested during the time the infant spends in the uterus. A new study published in Pediatric Obesity found that the types of normal bacteria found in the meconium may predict an infant's likelihood of later developing obesity.
  • New trial results question standard treatment plan for rheumatoid arthritis July 8, 2020
    In a clinical trial of patients with rheumatoid arthritis, treatment with a drug called upadacitinib provided greater benefits than methotrexate, the most commonly used initial therapy for rheumatoid arthritis.
  • Early clinical trial tests treatment strategy for pancreatic cancer July 8, 2020
    Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.